IRIS
DI IOIA, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.049
EU - Europa 1.694
AS - Asia 1.473
SA - Sud America 163
Continente sconosciuto - Info sul continente non disponibili 124
AF - Africa 24
OC - Oceania 6
Totale 6.533
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.949
SG - Singapore 519
CN - Cina 475
IT - Italia 248
DE - Germania 244
IE - Irlanda 226
UA - Ucraina 182
GB - Regno Unito 173
TR - Turchia 159
RU - Federazione Russa 155
SE - Svezia 147
BR - Brasile 136
VN - Vietnam 129
FI - Finlandia 112
FR - Francia 112
IN - India 68
CA - Canada 57
HK - Hong Kong 20
CZ - Repubblica Ceca 18
NL - Olanda 15
BE - Belgio 13
JP - Giappone 13
PL - Polonia 12
BD - Bangladesh 11
IQ - Iraq 10
CH - Svizzera 9
ZA - Sudafrica 9
MX - Messico 8
PK - Pakistan 8
ES - Italia 7
EU - Europa 7
ID - Indonesia 7
AR - Argentina 6
AU - Australia 6
CR - Costa Rica 6
HN - Honduras 6
IL - Israele 6
SA - Arabia Saudita 6
TT - Trinidad e Tobago 6
JO - Giordania 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
IR - Iran 4
JM - Giamaica 4
KR - Corea 4
MA - Marocco 4
MY - Malesia 4
NP - Nepal 4
PH - Filippine 4
PY - Paraguay 4
SC - Seychelles 4
VE - Venezuela 4
AM - Armenia 3
CO - Colombia 3
GP - Guadalupe 3
UZ - Uzbekistan 3
AT - Austria 2
DK - Danimarca 2
EC - Ecuador 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
KE - Kenya 2
KZ - Kazakistan 2
NI - Nicaragua 2
PE - Perù 2
RO - Romania 2
TN - Tunisia 2
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
HT - Haiti 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
OM - Oman 1
PR - Porto Rico 1
PT - Portogallo 1
SR - Suriname 1
SV - El Salvador 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
VI - Stati Uniti Isole Vergini 1
Totale 6.417
Salva come PNG Salva come JPEG
Città #
Singapore 384
San Jose 289
Chandler 288
Jacksonville 252
Dublin 223
Ashburn 198
Dallas 169
Beijing 145
Munich 139
Council Bluffs 118
Southend 116
Princeton 94
The Dalles 88
Nanjing 85
Ann Arbor 76
Izmir 73
Chieti 71
Los Angeles 69
New York 67
Dearborn 62
Santa Clara 58
Helsinki 53
Ho Chi Minh City 47
Wilmington 40
Cambridge 39
Buffalo 37
Altamura 32
Nanchang 29
Moscow 28
Tongling 27
Hanoi 26
Boardman 21
Montreal 20
Washington 19
Frankfurt am Main 18
Hong Kong 18
São Paulo 18
Woodbridge 18
Turku 17
Redondo Beach 16
Grevenbroich 15
Brno 14
Brooklyn 14
Kunming 14
Toronto 14
Denver 13
North Bergen 13
Shenyang 13
Brussels 12
Guangzhou 12
Houston 12
Jiaxing 12
London 12
Orem 12
Tokyo 12
Carrboro 11
Hebei 11
Norwalk 11
Tianjin 11
Amsterdam 10
Atlanta 10
Seattle 10
Columbus 9
Hangzhou 9
Phoenix 9
San Francisco 9
Stockholm 9
Warsaw 9
Baghdad 8
San Mateo 8
Changsha 7
Chicago 7
Fermo 7
Monmouth Junction 7
Nuremberg 7
Chennai 6
Dong Ket 6
Falls Church 6
Fribourg 6
Jinan 6
Lanzhou 6
Milan 6
Pescara 6
Poplar 6
Rome 6
Silver Spring 6
Amman 5
Belgrade 5
Camerino 5
Manchester 5
Mexico City 5
Mumbai 5
Roseto Degli Abruzzi 5
Ankara 4
Boston 4
Changchun 4
Charlotte 4
Curitiba 4
Da Nang 4
Edinburgh 4
Totale 4.089
Salva come PNG Salva come JPEG
Nome #
Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients 372
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis 236
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid 203
Cleavage of cystatin C is not associated with multiple sclerosis 184
Metabolomic Signature in Sera of Multiple Sclerosis Patients during Pregnancy 183
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 183
Integration of metabolomics and proteomics in multiple sclerosis: from biomarkers discovery to personalized medicine 177
UNRAVELING THE MOLECULAR REPERTOIRE OF TEARS AS A SOURCE OF BIOMARKERS: BEYOND OCULAR DISEASES 162
Increasing age at disability milestones among MS patients in the MSBase Registry 162
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center 162
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 159
Acetylcholine in multiple sclerosis: possible involvement in the modulation of the immune response and in oligodendrocyte recruitment. 159
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 153
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 152
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 152
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 151
Data of safety in a single-center alemtuzumab treated population 151
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 150
A difficult pediatric case: ADEM evolving in multiple sclerosis complicated by progressive multifocal leukoencephalopathy after Natalizumab treatment. 148
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 148
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 147
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 145
TLC-MALDI-Imaging approach for lipidomics studies in cerebrospinal fluid reveals low levels of sphingomyelin in multiple sclerosis patients 140
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 139
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 137
JCV-Ab serostatus in MS patients treated with Natalizumab 133
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 133
OXIDATIVE MODIFICATIONS OF CEREBRAL TRANSTHYRETIN ARE ASSOCIATED WITH MULTIPLE SCLEROSIS 132
Nail loss after teriflunomide treatment: a new potential adverse event 132
Natalizumab-associated PML-IRIS: the Chieti experience. 126
Multiphasic Adem or Multiple Sclerosis? Treatement implications. 124
Mass spectrometry based metabonomics of the cerebrospinalfluid highlights a correlation between polar lipids and carnitines levels in multiple sclerosis patients. 124
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group 123
Neuropsychological testing and quantitative electroencephalography: a search of neurophysiological markers of cognitive decline in multiple sclerosis 117
Patient adherence to and tolerability of self-administered interferon beta-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study 116
Prevalence of JC virus antibodies in human serum and seroconversion rate with first-generation and second generation ELISA: the novel assay improves specificity andsensitivity to detect anti-JC virus antibodies 115
Proteomic investigations on differential post-translational modification of transthyretin in multiple sclerosis. 115
Simultaneous early-onset severe autoimmune hemolytic anemia and albuminuria during alemtuzumab treatment for multiple sclerosis 106
Treatment discontinuation issues in fingolimod treated patients: the Chieti experience. 105
Relation between Pro-inflammatory Cytokines and Acetylcholine Levels in Relapsing-Remitting Multiple Sclerosis Patients 104
Progressive multifocal leukoencephalopathy associated with natalizumab in paediatric multiple sclerosis 102
Neuropsychological testing and event-related potentials: markers of cognitive impairment in patients with multiple sclerosis 99
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis 90
Lipidomics analysis reveals low levels of phosphatidylcholines and sphingomyelins in cerebrospinal fluido f multiple sclerosis patients. 88
Spinal cord injury in a patient with multiple sclerosis (MS) with secondary hydromyelia 84
Meta-analysis of metabolic biomarkers for multiple sclerosis identifies novel upstream regulators 10
Totale 6.533
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.737
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022173 0 0 0 0 9 13 10 20 16 9 24 72
2022/2023757 61 109 43 74 93 133 34 54 104 15 24 13
2023/2024394 17 18 33 6 30 181 48 5 1 8 2 45
2024/2025979 50 103 110 11 23 63 94 52 103 44 164 162
2025/20261.841 163 41 234 246 202 92 307 89 186 137 102 42
2026/2027548 31 80 112 216 109 0 0 0 0 0 0 0
Totale 6.533